A Novel Drug, CC-122, Inhibits Tumor Growth in Hepatocellular Carcinoma through Downregulation of an Oncogenic TCF-4 Isoform()()

Immunomodulatory drugs such as lenalidomide (LEN) have shown significant anti-tumor activity against hematologic malignancies and they may have similar actions on solid tumors as well. We studied the effect of a new analog of the immunomodulatory drugs (CC-122) on the growth of hepatocellular carcin...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Transl Oncol
Glavni autori: Tomimaru, Yoshito, Aihara, Arihiro, Wands, Jack R., Aloman, Costica, Kim, Miran
Format: Artigo
Jezik:Inglês
Izdano: Neoplasia Press 2019
Teme:
Original article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6664230/
https://ncbi.nlm.nih.gov/pubmed/31352197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2019.07.002
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items